TITLE

Outcome of the Rhomboid Flap for Recurrent Pilonidal Disease

AUTHOR(S)
Carriquiry, Luis A.
PUB. DATE
May 2009
SOURCE
World Journal of Surgery;May2009, Vol. 33 Issue 5, p1069
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
In this article the author discusses topic related to the use of excision and transposition of a rhomboid flap in treating a series of recurrent pilonidal dieses presented by O. el-Khadraway and company. The author emphasize that the technique deserve further widespread use in recurrent pilonidal disease. He also mentions that flap transposition can be undertaken in less than an hour, with careful technique and hemostasis.
ACCESSION #
37827225

 

Related Articles

  • Recombinant Factor VIIa for Life-Threatening Hemorrhage in Trauma Patients: Review of the Literature. Pape, Hans-Christoph; Erhardtsen, Elisabeth; Meyer, Christian; Leppäniemi, Ari Kalevi // European Journal of Trauma;Oct2006, Vol. 32 Issue 5, p439 

    The control of hemorrhage and coagulopathy is a vital component of trauma care, and failure to achieve hemostasis can contribute to mortality. Recombinant factor VIIa (rFVIIa) is a well-established therapy for bleeding episodes and surgical prophylaxis in hemophilia patients with inhibitors....

  • Effects of α1-acid glycoprotein on hemostasis in experimental septic peritonitis. M. Osikov; E. Makarov; L. Krivokhizhina // Bulletin of Experimental Biology & Medicine;Aug2007, Vol. 144 Issue 2, p178 

    Abstract  Pathogenesis of hemostasis disorders in septic peritonitis and the possibility of their correction with acute phase protein (α1-acid glycoprotein; two doses of 150 mg/kg) were experimentally studied on outbred albino rats. Platelets count in the peripheral blood and their...

  • The Involvement of Blood Coagulation Factor XIII in Fibrinolysis and Thrombosis. Muszbek, L.; Bagoly, Z.; Bereczky, Z.; Katona, É. // Cardiovascular & Hematological Agents in Medicinal Chemistry;2008, Vol. 6 Issue 3, p190 

    It has been known for a long time that blood coagulation factor XIII (FXIII) is essential for maintaining haemostasis, its deficiency leads to severe bleeding complication. Biochemical studies have revealed that FXIII is a key regulator of fibrinolysis and, in addition to its role in...

  • Recent advances in clot biology and assessment of clotting. Hedner, Ulla; Ezban, Mirella // Trauma;Oct2008, Vol. 10 Issue 4, p261 

    Since the first description of the haemostatic process by Morawitz in 1904, knowledge about the haemostasis mechanism has undergone substantial modifications. Increasing knowledge of enzymology, purification and characterisation of coagulation proteins led to the introduction of the waterfall or...

  • The use of recombinant activated coagulation factor VII for spine surgery. Weiskopf, Richard B. // European Spine Journal;Feb2004 Supplement 1, Vol. 13, pS83 

    This article focuses on our current understanding of the role of activated coagulation factor VII (FVIIa) in coagulation, the current evidence regarding the efficacy and safety of recombinant FVIIa (rFVIIa), and thoughts regarding the use of rFVIIa in spine surgery. rFVIIa is approved in many...

  • Letters to the Editor. Cohen, I. J.; Mammen, Eberhard F. // Clinical & Applied Thrombosis/Hemostasis;Fall1995, Vol. 1 Issue 4, p293 

    Presents letters to the editor referencing articles and topics discussed in previous issues. "Clinical and Applied Thrombosis/Hemostasis," which focused on hyperaggregation; Response to a letter to the editor concerning platelet hyperaggregability.

  • fi·brin.  // American Heritage Student Science Dictionary;2009, p129 

    A definition of the term "fibrin" is presented. It refers to a fibrous protein produced in response to bleeding that is the main component of blood clotting.

  • Recombinant Activated Factor VII: Current Perspectives and Epworth Experience Labattaglia, Matthew P.; Ihle, Benno // Heart, Lung & Circulation;Jun2007 Supplement 3, Vol. 16 Issue s3, pS96 

    Recombinant factor VII was first developed for control and prevention of bleeding in haemophilia with antibodies to factor VIII and IX. Its efficacy in these situations is well established. Over recent years, the ‘off-label’ use of this substance has become more widespread in...

  • Comparison of ultrasonic energy, bipolar thermal energy, and vascular clips for the hemostasis of small-, medium-, and large-sized arteries. Harold, K.L.; Pollinger, H.; Matthews, B.D.; Kercher, K.W.; Sing, R.F.; Heniford, B.T. // Surgical Endoscopy;Aug2003, Vol. 17 Issue 8, p1228 

    Background: Advanced laparoscopic procedures have necessitated the development of new technology for vascular control. Suture ligation can be time-consuming and cumbersome during laparoscopic dissection. Titanium clips have been used for hemostasis, and recently plastic clips and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics